tag: why it’s moving

Inhibikase Therapeutics Inc IKT shares are trading higher by 31.1% to $1.56 during Wednesday’s session after the company announced the pricing of an approximately $110 million private placement financing. What Else: Inhibikase says…

Editor’s note: This story has been updated with additional information. Markets are bouncing Wednesday afternoon following the Federal Reserve’s decision to cut rates by 0.5%, marking the beginning of the central bank’s highly…